Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 906-891-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The substance is not mutagenic.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-08-14 until 2010-09-13
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: according to OECD 476
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Principles of method if other than guideline:
- first experiment: 4 hours treatment with and without metabolic activation
second experiment: 24 hours treatment without metabolic activation, 4 hours treatment with metaoblic activation - GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- Thymidine Kinase Locus
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RPMI
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Additional strain / cell type characteristics:
- other: Clone 3.7.2C
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/Beta-Naphtoflavone induced Rat liver S9
- Test concentrations with justification for top dose:
- Experiment I:
without S9 mix: 45.7; 91.3; 182.5; 365; 730; and 1460 µg/mL
with S9 mix: 45.7; 91.3; 182.5; 365; 730; and 1460 µg/mL
Experiment II:
without S9 mix: 91.3; 182.5; 365; 730; 1095; and 1460 µg/mL
with S9 mix: 91.3; 182.5; 365; 730; 1095; and 1460 µg/mL
Following the expression phase of 48 hours the cultures at the lowest concentrations in experiment I and II with and without metabolic activation were not continued since a minimum of only four analysable concentrations is required by the guidelines. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: deionised water (10 %)
- Justification for choice of solvent/vehicle: solubility properties - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 hours with and without metabolic activation in experiment 1, 24 hours without metaoblic activation in experiment and 4 hours with metabolic activation in experiment 2
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): 10 to 15 days
SELECTION AGENT (mutation assays): RPMI 1640 medium by addition of 5 µg/mL TFT
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: >1,5 x 10 exp. 6 cells
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
- Evaluation criteria:
- A test item is classified as mutagenic if the induced mutation frequency reproducibly exceeds a threshold of 126 colonies per 10 exp. 6 cells (global evaluation factor, GEF) above the corresponding solvent control. The GEF was introduced by the International Workshop on Genotoxicity Testing (IWGT) to replace the former threshold of twice the mutation frequency of the corresponding solvent control (12).
A relevant increase of the mutation frequency should be dose-dependent.
A mutagenic response is considered to be reproducible if it occurs in both parallel cultures.
However, in the evaluation of the test results the historical variability of the mutation rates in the solvent con¬trols of this study are taken into consideration.
Results of test groups are generally rejected if the relative total growth is less than 10 % of the vehicle control unless the exception criteria specified by the IWGT recommendations are fulfilled.
Whenever a test item is considered mutagenic according to the above mentioned criteria, the ratio of small versus large colonies is used to differentiate point mutations from clastogenic effects. If the increase of the mutation frequency is accompanied by a reproducible and dose dependent shift in the ratio of small versus large colonies clastogenic effects are indicated. - Statistics:
- Linear regression analysis (least squares) using SYSTAT(R) 11 (SYSTAT Software, Inc., 501, Canal Boulevard, Suite C, Richmond, CA 94804, USA)
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: the pH was adjusted with 2N HCl at the maximum test item concentration in the pre-experiment
- Effects of osmolality: Not increased
- Evaporation from medium: Not examined
- Water solubility: --
- Precipitation: none
- Other confounding effects: none
RANGE-FINDING/SCREENING STUDIES:
The pre-experiment was performed in the presence (4 h treatment) and absence (4 h and 24 h treatment) of metabolic activation. Test item concentrations between 11.4 µg/mL and 1460 µg/mL were used. The highest concentration in the pre-experiment was about 10 mM based on the
purity (100 % active ingredient) and the molecular weight (approx. 146 g/mol) of the test item.
Relevant toxic effect (relative suspension growth, RSG below 50% of the solvent control) occurred at 365 µg/mL and above following 24h
treatment without metabolic activation.
The test medium was checked for precipitation at the end of each treatment period (4 or 24 hours) before the test item was removed. No
precipitation was observed up to the maximum concentration with and without metabolic activation following 4 and 24 hours treatment.
In the pre-experiment the three highest concentrations were neutralised with 1 N sodium hydroxide. There was no relevant shift of osmolarity of the medium even at the maximum concentration of the test item.
Therefore, the maximum concentration of the main experiments was adjusted according to the results of the pre-experiment. In both main
experiments the individual concentrations were generally spaced by a factor of 2.0 in the lower range. In the second experiment a narrower
spacing was used at the highest concentrations to cover the cytotoxic range more closely.
To overcome problems with possible deviations in toxicity or solubility both main experiments were started with more than four concentrations.
COMPARISON WITH HISTORICAL CONTROL DATA: Complies
ADDITIONAL INFORMATION ON CYTOTOXICITY: None - Remarks on result:
- other: strain/cell type: in vitro gene mutation assay with L5178Y cells
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- In conclusion it can be stated that under the experimental conditions reported the test item did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation.
- Executive summary:
The study was performed to investigate the potential of Ethanol, 2-amino-, reaction products with ammonia, by-products from (CAS No.: 68910-05-4) to induce mutations at the mouse lymphoma thymidine kinase locus using the cellline L5178Y.
The study was conducted according to the procedures indicated by the following internationally accepted guidelines and recommendations:
Ninth Addendum to the OECD Guidelines for Testing of Chemicals, February 1998,
adopted, Guideline No. 476 “In vitro Mammalian Cell Gene Mutation Test”.Commission Regulation (EC) No. 440/2008, B17: “Mutagenicity – In vitro Mammalian Cell Gene Mutation Test“, dated.
The assay was performed in two independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a treatment period of 4 h. The second experiment was performed with a treatment period of 4 h with and
24 h without metabolic activation.
The main experiments were evaluated at the following concentrations:
Experiment I:
without S9 mix: 91.3; 182.5; 365; 730; and 1460 µg/mL
with S9 mix: 91.3; 182.5; 365; 730; and 1460 µg/mLExperiment II:
without S9 mix: 182.5; 365; 730; 1095; and 1460 µg/mL
with S9 mix: 182.5; 365; 730; 1095; and 1460 µg/mLNo precipitation of the test item visible to the naked eye was determined in both experiments up to the maximum concentration with and without metabolic activation.
No relevant toxic effects indicated by a relative total growth of less than 50 % of survival in both parallel cultures were observed in both main experiments up to the maximum concentration with and without metabolic activation, following 4 hours of treatment. After 24 hours of treatment (second experiment without metabolic activation) cytotoxic effects as described above occurred at 730 µg/mL and above. The data generated in both cultures of experiment II at 1460 µg/mL without metabolic activation are not considered valid since the relative total growth fell short of the threshold of 10%. The recommended cytotoxic range of approximately 10-20% RTG was covered in the second experiment without metabolic activation.
No substantial and reproducible dose dependent increase of the mutation frequency was observed in both experiments with and without metabolic activation. The mutation frequency did not reach or exceed the threshold of 126 plus each solvent control count.
A linear regression analysis (least squares) was performed to assess a possible dose dependent increase of the mutation frequency using SYSTAT (R) 11 statistics software. A significant dose dependent trend of the mutation frequency indicated by a probability value of <0.05 was solely determined in the first culture of experiment II with metabolic activation. This trend however, was not considered relevant since it was not reproduced in the parallel culture and all of the absolute values of the mutation frequency remained within the historical range of solvent controls.
In this study the range of the solvent controls was from 59 up to 131 mutant colonies per 106cells; the range of the acceptable groups treated with the test item was from 41 up to 178 mutant colonies per 106cells.
The cloning efficiency exceeded the upper limit of 120% in the second culture of the first experiment and the first culture of the second experiment with metabolic activation. The data are acceptable however, since the cloning efficiency of the parallel culture remained within the acceptable range. Cloning efficiency values above 100% occasionally occur since even suspension cell cultures do not form an ideal solution in medium. The cells tend to form transient aggregates that are counted as single cells during determination of the cell density. The aggregation does not compromise the validity of the data however, since the absolute values of the cloning efficiency are used to calculate the mutation frequency.
MMS (19.5 µg/mL in experiment I and 13.0 µg/mL in experiment II) and CPA (3.0 and 4.5 µg/mL) were used as positive controls and showed a distinct increase in induced total mutant colonies and an increase of the relative quantity of small versus large induced colonies. The CPA-control of the second culture of the second experiment did not quite meet the acceptance criteria (at least 150 induced small colonies) even though the total number of mutant colonies showed a substantial increase from 92 to 313 colonies per 106cells at 4.5 µg/mL. However, more than half of the induced colonies were large ones. The data are acceptable since the corresponding positive control of the parallel culture met the acceptance criteria.
Reference
Summary Table
relative | mutant | relative | mutant | |||||
conc. µg | S9 | total | colonies/ | total | colonies/ | |||
per mL | mix | growth | 106cells | threshold | growth | 106cells | threshold | |
Column | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
Experiment I / 4 h treatment | culture I | culture II | ||||||
Solv. control with water | - | 100.0 | 123 | 249 | 100.0 | 89 | 215 | |
Pos. control with MMS | 19.5 | - | 37.3 | 373 | 249 | 17.2 | 950 | 215 |
Test item | 45.7 | - | culture was not continued# | culture was not continued# | ||||
Test item | 91.3 | - | 118.5 | 94 | 249 | 93.7 | 101 | 215 |
Test item | 182.5 | - | 116.5 | 120 | 249 | 93.2 | 113 | 215 |
Test item | 365.0 | - | 104.5 | 95 | 249 | 108.9 | 115 | 215 |
Test item | 730.0 | - | 104.9 | 89 | 249 | 120.9 | 97 | 215 |
Test item | 1460.0 | - | 86.4 | 123 | 249 | 93.7 | 101 | 215 |
Solv. control with water | + | 100.0 | 131 | 257 | 100.0 | 66 | 192 | |
Pos. control with CPA | 3.0 | + | 72.2 | 190 | 257 | 28.9 | 211 | 192 |
Pos. control with CPA | 4.5 | + | 30.1 | 446 | 257 | 28.3 | 252 | 192 |
Test item | 45.7 | + | culture was not continued# | culture was not continued# | ||||
Test item | 91.3 | + | 128.5 | 114 | 257 | 66.5 | 118 | 192 |
Test item | 182.5 | + | 125.7 | 97 | 257 | 42.9 | 124 | 192 |
Test item | 365.0 | + | 170.7 | 98 | 257 | 83.2 | 71 | 192 |
Test item | 730.0 | + | 176.8 | 73 | 257 | 44.7 | 140 | 192 |
Test item | 1460.0 | + | 149.5 | 85 | 257 | 48.2 | 106 | 192 |
Experiment II / 24 h treatment | culture I | culture II | ||||||
Solv. control with water | - | 100.0 | 59 | 185 | 100.0 | 113 | 239 | |
Pos. control with MMS | 13.0 | - | 19.2 | 336 | 185 | 14.8 | 564 | 239 |
Test item | 91.3 | - | culture was not continued# | culture was not continued# | ||||
Test item | 182.5 | - | 114.3 | 41 | 185 | 61.0 | 105 | 239 |
Test item | 365.0 | - | 53.5 | 100 | 185 | 53.0 | 95 | 239 |
Test item | 730.0 | - | 29.9 | 114 | 185 | 26.7 | 112 | 239 |
Test item | 1095.0 | - | 16.0 | 123 | 185 | 20.9 | 111 | 239 |
Test item | 1460.0 | - | 7.7 | 153 | 185 | 7.3 | 228 | 239 |
Experiment II / 4 h treatment | culture I | culture II | ||||||
Solv. control with water | + | 100.0 | 59 | 185 | 100.0 | 92 | 218 | |
Pos. control with CPA | 3.0 | + | 57.0 | 133 | 185 | 88.2 | 135 | 218 |
Pos. control with CPA | 4.5 | + | 9.7 | 303 | 185 | 53.9 | 313 | 218 |
Test item | 91.3 | + | culture was not continued# | culture was not continued# | ||||
Test item | 182.5 | + | 91.2 | 63 | 185 | 105.9 | 67 | 218 |
Test item | 365.0 | + | 105.3 | 57 | 185 | 112.8 | 80 | 218 |
Test item | 730.0 | + | 98.1 | 79 | 185 | 122.6 | 72 | 218 |
Test item | 1095.0 | + | 65.9 | 79 | 185 | 121.6 | 55 | 218 |
Test item | 1460.0 | + | 68.5 | 99 | 185 | 133.5 | 178 | 218 |
Threshold = number of mutant colonies per 106cells of each solvent control plus 126
# culture was not continued since a minimum of only 4 analysable concentrations is required
The values printed in bold are judged as invalid, since the acceptance criteria are not met (RTG < 10%).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Additional information from genetic toxicity in vitro:
I Triethylenetetramine, which is a major constituent of this multiconstituent substace, has been found positive in Ames in vitro tests, but has given negative results in an in-vivo Mammalian Erythrocyte Micronucleus Test, according to OECD Guideline 474.
The substance has been tested in an Ames test, and found positive. The test item was assessed for its potential to induce gene mutations according to the plate incorporation test (experiment I) using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and TA 102. The assay was performed in an experiments with and without liver microsomal activation. Substantial and dose dependent increases in revertant colony numbers were observed following treatment with the substance in strains TA 98,100, and TA 102 in the presence and absence of metabolic activation (S9 mix).
Further in-vitro testing in a mammalian cell gene mutation test gave a negative response. The study was performed to investigate the potential of Ethanol, 2-amino-, reaction products with ammonia, by-products from (CAS No.:
68910-05-4) to induce mutations at the mouse lymphoma thymidine kinase locus using the cellline L5178Y. The study was conducted according to the procedures indicated by the following internationally accepted guidelines and recommendations:
Ninth Addendum to the GECD Guidelines for Testing of Chemicals, February 1998,adopted, Guideline No. 476 "In vitro Mammalian Cell Gene Mutation Test. Commission Regulation (EC) No. 440/2008, B17: "Mutagenicity - In vitro Mammalian Cell Gene Mutation Test. The assay was performed in two independent experiments, using two parallel cultures each. The first main experiment was performed with and without liver microsomal activation and a treatment period of 4 h. The second experiment was performed with a treatment period of 4 h with and 24 h without metabolic activation. No substantial and reproducible dose dependent increase of the mutation frequency was observed in both experiments with and without metabolic activation. The mutation frequency did not reach or exceed the threshold of 126 plus each solvent control count. A linear regression analysis (least squares) was performed to assess a possible dose dependent increase of the mutation frequency using SYSTAT (R) 11 statistics software. A significant dose dependent trend of the mutation frequency indicated by a probability value of <0.05 was solely determined in the first culture of experiment II with metabolic activation. This trend however, was not considered relevant since it was not reproduced in the parallel culture and all of the absolute values of the mutation frequency remained within the historical range of solvent controls.
Based on the results in the draft in-vitro mammalian cell gene mutation test and the in-vivo test performed on the major constituent triethylenetetramine, the substance is considered to be not mutagenic.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.